نتایج جستجو برای: thalassemia preventing program

تعداد نتایج: 555836  

Journal: :Thalassemia Reports 2021

Thalassemia is an autosomal recessive disease that common in Iraq with a prevalence of 35.7 per 100,000. It the most type hereditary anemia registered 2015. life-threatening condition many complications which if not managed could cause death early age. This study aimed to assess awareness Iraqi people about thalassemia transmission and prevention find their source information disease, as develo...

Journal: :The Southeast Asian journal of tropical medicine and public health 2007
H Rosline T M Roshan S A Ahmed I Ilunihayati

Thalassemia is a common public health problem among Malays. Hemoglobin C (Hb C) is a hemoglobin beta variant resulting from a single base mutation at the 6th position of the beta-globin gene leading to the substitution of glycine for glutamic acid. Hb C is commonly detected in West Africans and in African American but has not been reported in Malaysia. It can be falsely diagnosed as HbE trait i...

2015
Antonella Meloni Lorella Pitrolo Mari Giovanna Neri Gennaro Restaino Chiara Tudisca Paolo Preziosi Petra Keilberg Sabrina Armari Vincenzo Positano Alessia Pepe

Background There are no prospective studies comparing the effectiveness of the three iron chelators commercially available in preventing or decreasing iron overload in the heart in pediatric thalassemia major (TM) patients. Our aim was to evaluate the changes in cardiac iron and function by quantitative magnetic resonance imaging (MRI) over a follow-up (FU) of 18 months in pediatric TM patients...

2011

NEW DRUGS Ferriprox Reduces Excess Iron Deferiprone (Ferriprox, Apo-Pharma, Inc.) has been approved to treat iron overload resulting from blood transfusions in patients with thalassemia who have responded inadequately to previous chelation therapy. Thalassemia is a genetic blood disorder that causes anemia. Patients with thalassemia have excess iron levels from frequent blood transfusions, a se...

جلالی, حسین, خوش آئین, عاطفه, مهدوی, محمدرضا, کوثریان, مهرنوش, روشن, پیام ,

 Background: Beta thalassemia is one of the most common hereditary disorders worldwide. In Iran, it is frequently reported from northern and southern provinces. In order to prevent child birth affected by this complication, prenatal screening and diagnosis is carried out nationwide. However in some instances, this program is unable to identify rare mutations leading to thalassemia. Case ...

کرم بین, دکتر محمد مهدی ,

ABSTRACT Thalassemia is a genetic disease, which is prevalent in Guilan province. In order to detect thalassemia gene carries, Screening program was performed in high school students of the Rasht City, with cooperation of Guilan Medical University. Complete blood count and blood indices were reviewed in 22136 students, and Hb. Electrophoresis (with helena equipment) were performed in cases wi...

Journal: :Haematologica 2007
Leonilde Pagano Assunta Viola Gennaro Fioretti Massimiliano Ammirabile Paolo Ricchi Luciano Prossomariti

Between January 1995 and December 2005, we conducted a screening program for the presence of Hb Neapolis, a rare abnormal Hb variant, in Campania, a region in Southern Italy. Nineteen patients with Hb Neapolis in heterozygosis and six patients with a genetic compound (Hb Neapolis/beta-thalassemia) were identified. Patients with Hb Neapolis in heterozygosis showed a slight alteration in HbA2 lev...

2014
Leela Pant Dipti Kalita Sompal Singh Madhur Kudesia Sumanlata Mendiratta Meenakshi Mittal Alka Mathur

Thalassemia and thalassemic hemoglobinopathies pose serious health problem leading to severe morbidity and mortality in Indian population. Plethora of hemoglobin variants is prevalent in multiethnic Indian population. The aim of the present study was to analyze laboratory aspects, namely, hematological profile and HPLC findings of the hemoglobin variants detected, and to discuss problems that w...

2013
Srdjan Denic Mukesh M. Agarwal Bayan Al Dabbagh Awad El Essa Mohamed Takala Saad Showqi Javed Yassin

Screening for β -thalassemia trait (BTT) relies on measuring hemoglobin (Hb) A2. Since multiple factors can affect HbA2 levels, the screening can become unreliable. In 1356 healthy Arabs enrolled into a federally funded premarital BTT screening program, the effects of iron deficiency (ID), α (+)-thalassemia trait, gender, smoking, and tribalism on HbA2 were studied. The complete blood count and...

2017
Phetcharat Phanthong Suparerk Borwornpinyo Narisorn Kitiyanant Natee Jearawiriyapaisarn Lalana Nuntakarn Jirawat Saetan Tiwaporn Nualkaew Khanit Sa‐ngiamsuntorn Usanarat Anurathapan Andras Dinnyes Yindee Kitiyanant Suradej Hongeng

The therapeutic use of patient-specific induced pluripotent stem cells (iPSCs) is emerging as a potential treatment of β-thalassemia. Ideally, patient-specific iPSCs would be genetically corrected by various approaches to treat β-thalassemia including lentiviral gene transfer, lentivirus-delivered shRNA, and gene editing. These corrected iPSCs would be subsequently differentiated into hematopoi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید